Takeshi Yanagi
Overview
Explore the profile of Takeshi Yanagi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
658
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takaoka T, Yanagi T, Takahashi S, Shibamoto Y, Imai Y, Okazaki D, et al.
Phys Imaging Radiat Oncol
. 2024 May;
30:100583.
PMID: 38711921
Background And Purpose: Interfractional geometrical and anatomical variations impact the accuracy of proton therapy for pancreatic cancer. This study investigated field-in-field (FIF) and simultaneous integrated boost (SIB) concepts for scanned...
2.
Takaoka T, Yanagi T, Tanaka A, Kiriyama Y, Tanaka Y, Kondo T, et al.
Jpn J Clin Oncol
. 2023 Feb;
53(5):419-428.
PMID: 36722357
Background: The purpose of this study was to evaluate the incidence of acute genitourinary toxicities in patients undergoing pencil beam scanning proton therapy for prostate cancer and investigate predictive factors...
3.
Yanagi T, Takama N, Kato E, Baba F, Kitase M, Shimohira M, et al.
Kurume Med J
. 2022 Nov;
67(4):163-170.
PMID: 36450483
Objective: The aim of this study is to evaluate the utility of adjuvant radiotherapy (intraoperative radiotherapy, IORT; postoperative radiotherapy, PORT), and definitive radiotherapy for non-metastatic pancreatic cancer. Methods: Ninety-nine patients...
4.
Kita N, Shibamoto Y, Takemoto S, Manabe Y, Yanagi T, Sugie C, et al.
J Radiat Res
. 2022 Jun;
63(4):666-674.
PMID: 35726342
The outcomes of three methods of intensity-modulated radiation therapy (IMRT) for localized prostate cancer were evaluated. Between 2010 and 2018, 308 D'Amico intermediate- or high-risk patients were treated with 2.2...
5.
Takaoka T, Tomita N, Mizuno T, Hashimoto S, Tsuchiya T, Tomida M, et al.
Technol Cancer Res Treat
. 2021 Nov;
20:15330338211060170.
PMID: 34806489
Cognitive decline and alopecia after radiotherapy are challenging problems. We aimed to compare whole brain radiotherapy (WBRT) plans reducing radiation dose to the hippocampus and scalp between helical tomotherapy (HT)...
6.
Sawai H, Ueno S, Yamaguchi Y, Suzuki Y, Murata A, Suganuma E, et al.
Am J Case Rep
. 2021 Aug;
22:e931564.
PMID: 34400601
BACKGROUND Radiofrequency (RF) hyperthermia is commonly used as an adjunct to established treatment modalities such as chemotherapy and radiotherapy for the management of cancer patients. This case report aims to...
7.
Okazaki D, Shibamoto Y, Yanagi T, Ishikura S, Kondo T, Yamada Y, et al.
J Radiat Res
. 2021 May;
62(4):676-681.
PMID: 34036359
Pleural dissemination is a common pattern of failure after initial treatment of thymoma and thymic carcinoma, but there is no standardized treatment. As these tumors are relatively radiosensitive, we investigated...
8.
Takemoto S, Shibamoto Y, Hashizume C, Miyakawa A, Murai T, Yanagi T, et al.
J Radiat Res
. 2021 Jan;
62(2):338-345.
PMID: 33480428
It is desirable to estimate the degree of the decrease in pulmonary function before lung stereotactic body radiation therapy (SBRT) especially for patients with poor pulmonary function. The purpose of...
9.
Ishikura S, Kondo T, Murai T, Ozawa Y, Yanagi T, Sugie C, et al.
J Radiat Res
. 2020 Apr;
61(3):464-469.
PMID: 32249307
Definitive chemoradiotherapy (dCRT) is the standard treatment for unresectable esophageal cancer. Induction chemotherapy has been actively investigated for borderline-resectable and unresectable disease, but the superiority over dCRT has yet to...
10.
Takemoto S, Shibamoto Y, Sugie C, Manabe Y, Yanagi T, Iwata H, et al.
J Radiat Res
. 2018 Dec;
60(2):221-227.
PMID: 30566649
We evaluated long-term outcomes of three protocols of intensity-modulated radiation therapy (IMRT) for localized prostate cancer. Between 2005 and 2014, 348 patients were treated with 5-field IMRT. The first 74...